Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05216796 · ClinicalTrials.gov registry record · NA
Healthy Liver - Healthy Brain
A NA study of PreDiabetes and Metabolic Syndrome, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05216796: Completed NA study of PreDiabetes and Metabolic Syndrome, sponsored by University of Texas at Austin.
NCT05216796 is a NA study of PreDiabetes and Metabolic Syndrome that has completed, run by University of Texas at Austin. The registered enrollment target is 55 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05216796, a NA study of PreDiabetes and Metabolic Syndrome, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.
Primary Outcome
Hepatic triglyceride level will be assessed using liver 1H MRS.
Conditions Studied
Interventions
- BEHAVIORAL Diet Intervention
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
What the finished NCT05216796 record still lists
NCT05216796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (92% lower).
The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Diet Intervention is the first listed.
NCT05216796 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05216796 about?
NCT05216796 is a clinical study titled "Healthy Liver - Healthy Brain". People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain ...
What is the current status of trial NCT05216796?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2022-05-18. Estimated completion is 2024-09-01.
What conditions does trial NCT05216796 study?
This clinical trial studies the following conditions: PreDiabetes, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, NAFLD.
What interventions are being tested in trial NCT05216796?
The interventions under investigation include: Diet Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05216796?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05216796 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05216796's enrollment target sits among peer trials
55 99th of 149 higher than 51 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI